Insider filing · TXG
Adam Taich
Chief Financial Officer
profile →
10x Genomics, Inc.
TXG · Healthcare · 28 filings in 24 months
ticker →
Adam Taich sold $2.9M of 10x Genomics (TXG)
Executed Sep 9, disclosed Sep 11, 2 days later.
Value, as filed
$2.9M
45,182 sh across 2 lots
Executed
Sep 9
the trade date, as filed
Disclosed
Sep 11
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ATAdam Taich (Chief Financial Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in 10x Genomics, Inc. (TXG). The largest single filing was $2.9M of TXG (45,182 sh across 2 lots, as filed), executed Sep 9.
The name
TXGHealthcare · 10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Adam Taich in TXG
TXGSALE
10x Genomics, Inc.
$1.1M17,166 sh × $63.02
Exec Aug 24
Filed Aug 26 · 4:44 PM ET TXGSALE 10x Genomics, Inc. $369K
15,098 sh × $24.44
Exec May 22
Filed May 27 · 5:30 PM ET TXGSALE 10x Genomics, Inc. $167K
8,968 sh × $18.58
Exec Feb 23
Filed Feb 25 · 5:30 PM ET TXGSALE 10x Genomics, Inc. $226K
11,888 sh × $19.00
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET TXGSALE 10x Genomics, Inc. $308K
22,315 sh × $13.79
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET